Open AccessUsing a single tablet regimen of darunavir, cobicistat, emcitrabine, and tenofovir alafenamide in virally suppressed HIV-1 patients is an adequate treatment option for controlling HIV
Author(s) -
Priya Kathuria
Publication year - 2021
Publication title -
clinical research in practice
Language(s) - English
Resource type - Journals
ISSN - 2379-4550
DOI - 10.22237/crp/1625097720
Subject(s) - cobicistat , darunavir , tenofovir alafenamide , emtricitabine , medicine , human immunodeficiency virus (hiv) , virology , regimen , pharmacology , viral load , antiretroviral therapy